Metabolic health research
Obesity is an increasing problem. Our Metabolic Health Research (MHR) expertise group helps to reduce the burden of disease through preclinical research. We focus on metabolic diseases, such as type-2 diabetes and obesity. With research, we accelerate the development of new drugs, functional foods, diagnostics, and prevention.
Our MHR expertise group develops cellular and animal models to study mechanisms, interventions, and biomarkers in metabolic diseases, and the associated complications. In preclinical research, we apply the following models:
- Translational models, including unique, humanised transgenic mouse models.
- In vivo and in vitro fibrosis models, combined with histological, biochemical, molecular biological, cell biological, and immunological analysis methods.
We focus on improving research on the effectiveness and safety of interventions using drugs or food. We do this by increasing knowledge of disease processes and mechanisms, and we improve the translation to humans.
Knowledge and experience
We have extensive experience in the design and implementation of applied scientific research. In addition, we invest heavily in professional project management and work with quality systems. We deliver customised projects through the direct interaction of our MHR scientists with clients.
Metabolic disease and complications
The projects are characterised by a combination of knowledge and expertise in the field of metabolic health and metabolic disease, and the associated complications, such as:
- cardiovascular diseases
- hepatic steatosis
Within MHR, we work on projects with and for partners, such as:
- industrial biotechnology
- pharmaceutical industry
- food industry
- patient organisations
- public authorities
Our research provides new insights and possibilities for treating or preventing metabolic diseases. A few examples:
- A diet in which we alternate cholesterol-free food with ‘Western’ food containing a lot of cholesterol. This has a more or less similar effect on the prevention of cardiovascular disease and liver inflammation as a completely cholesterol-free diet.
- Metabolic stress, caused by being overweight, plays a more prominent role in the development of osteoarthritis than higher mechanical stress.
- A new statistical approach leads to a reduction in laboratory animal use.
Possibilities for visualising and analysing body fat in laboratory animals using non-invasive MRI.
Arjen AmelinkFunctie:Principal Scientist Medical Photonics
The chair focuses on the development and clinical validation of new optical diagnostic methods, with an emphasis on the interpretation of data generated by optical measurement systems based on the modeling of light transport in biological tissues.
Ben van OmmenFunctie:Principal Scientist Specialist
Looking for another expert?View all experts
UK MasterChef winner Tim Anderson experiments with 3D printed pasta
The winner of MasterChef UK series 7, Tim Anderson, experiments with 3D printed pasta from BluRhapsody, a collaboration between Italian pasta makers Barilla and TNO. The results were satisfactory. Kjeld van Bommel, senior consultant 3D Food and Pharma Printing at TNO, explains how the triple collaboration took shape.
Autonomous systems in the real world
Are autonomous systems like self-driving cars also safe without human input? TNO develops hybrid AI algorithms for this purpose. Read more.
Risk analysis for products in development
RAPID conducts research into the quality and safety of chemical substances, food ingredients and products, drugs, and nanoparticles.
Microbiology and systems biology
Our Microbiology and Systems Biology (MSB) expertise group uses systems biology to address challenging issues.
TNO contributes to improving the health of young people and their parents. Through scientific research, guideline development, and education, among other things.